Navigation Links
Bruin Biometrics Formalizes Management Structure with Appointment of Jeff Greiner and Eve Kurtin to Board of Directors, Plus Additional Executive Leadership
Date:12/2/2013

LOS ANGELES, Dec. 2, 2013 /PRNewswire/ -- Bruin Biometrics, LLC ("BBI") a medical device company developing innovative, point of care diagnostic devices, announced today the appointment of two new board members and the expansion of the executive team.

(Logo; http://photos.prnewswire.com/prnh/20131018/LA00429LOGO)

Jeff Greiner joins the BBI board after serving 18 years leading Advanced Bionics, a medical device company that developed spinal cord stimulators and cochlear implants. The company was sold for over $3 billion dollars and is now owned by Boston Scientific (neuromodulation division) and Sonova (cochlear implant division).

Eve Kurtin joins the BBI Board with over 20 years of experience as an operating executive and investor in healthcare. Eve is Managing Director of Pacific Venture Group and Senior Advisor of VantagePoint Capital Partners. She is also a founding member of the RAND Health Board of Advisors, an assembly of national leaders working to improve the U.S. healthcare system.

Rob Pecsar joins BBI as Vice President of Research & Development. Rob has previously launched 18 medical products at a variety of companies including Alaris Medical Systems, Cardinal Health, CareFusion, Gen-Probe, IMED, and Infrasonics, Inc.

Armin Beck joins BBI as Vice President of Quality, Regulatory, Manufacturing, and Operations. He has over 30 years experience leading international commercial product launches and most recently directed Quality Assurance, Regulatory, and Clinical Affairs at Cardica, Inc.

Mark Bruns joins BBI as Vice President of Commercial Operations and Sales. Mark has over 30 years of experience, most recently as a transformational leader in sales and marketing at Alaris Medical Systems, Cardinal Health, and CareFusion.

Sally Grigoriev joins BBI as Senior Advisor, Operations. Sally was previously Senior Vice President of Manufacturing and Operations at CareFusion and Cardinal Health.  She has over 25 years of R&D, Quality, Regulatory, Manufacturing, and Operations experience within the medical device industry.

BBI Chief Executive Martin Burns commented, "We have been extremely diligent about finding the right people who understand BBI's strategy and also have the talent to execute upon BBI's business goals. Our combined team has launched over 30 medical products and technologies, and we are united in our mission to solve pressing clinical challenges."

To learn more about BBI please visit www.bruinbiometrics.com.


'/>"/>
SOURCE Bruin Biometrics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bruin Biometrics, LLC führt klinische Studie zum Nachweis von Druckgeschwüren mit dem SEM Scanner durch
2. Bruin Biometrics, LLC Conducts Clinical Trials to Detect Pressure Ulcers with the SEM Scanner
3. Bruin Biometrics, LLC Announces New Board Members
4. Synteract Appoints Keith Kelson as Chief Financial Officer and Member of Executive Council and Philip Doren, Ph.D., as Vice President, Biometrics
5. Biometrics Limits Abuse while Improving Convenience
6. Virtify Announces Second Webinar on Regulatory Information Management Strategies for Small and Mid-Sized Pharmas
7. Lorus Therapeutics Completes New Executive Management Team
8. The Modern Algorithm For Management Of Massive And Submassive Pulmonary Embolism
9. The Huntzinger Management Group, Inc. (HMG) Reporting Significant Growth and Business Expansion in 2013
10. Array BioPharma Announces Management Team Change
11. Implantable Medical Device Group formed to Reduce Risk and Simplify Management of Active Implant Projects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... 2017 , ... Donna Parker, L. Ac. reads all sorts of books on ... to be very practical. She wanted to write a guide/workbook that would give readers ... It prompted her in writing “ A Clear Path to a Vibrant Life : ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is ... the process rendered in my Art and Music. These are created as Metaphysical Transformations ... the boundary of mystery culminate to the ultimate singularity.", -- Karen Salicath Jamali , ...
(Date:4/22/2017)... (PRWEB) , ... April 22, 2017 , ... ... to his role as Vice President of Sales and Business Development at OAKWORKS, ... GPO/IDN business partner engagements, business development, and strategic planning for the company. ...
(Date:4/21/2017)... ... April 21, 2017 , ... Contrary ... that youth violence is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright ... people involved in violence in the United States. The study, Trends in ...
Breaking Medicine News(10 mins):